G. Weijers

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome

G. Schuurhuis, G. Ossenkoppele, P. Huijgens, 2003, Leukemia.

Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts.

G. Schuurhuis, E. van der Wall, P. Huijgens, 2002, Journal of hematotherapy & stem cell research.

Immunologic Purging of Autologous Peripheral Blood Stem Cell Products Based on CD34 and CD133 Expression Can Be Effectively and Safely Applied in Half of the Acute Myeloid Leukemia Patients

G. Schuurhuis, G. Ossenkoppele, N. Feller, 2005, Clinical Cancer Research.

Research Report Early Apoptosis Largely Accounts for Functional Impairment of CD34 1 Cells in Frozen- Thawed Stem Cell Grafts

G. Schuurhuis, E. Wall, P. Huijgens, 2002 .

Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis

G. Schuurhuis, G. Ossenkoppele, N. Feller, 2003, Leukemia.

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

G. Schuurhuis, G. Ossenkoppele, N. Feller, 2004, Leukemia.

Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.

G. Schuurhuis, G. Ossenkoppele, A. van Loevezijn, 2003, Haematologica.